Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
2016
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
2013
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up
2016
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Targeting B cells for the treatment of rheumatoid arthritis.
2003
Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
2008 StandoutNobel
Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles
2006
The PI3K/AKT Pathway as a Target for Cancer Treatment
2015
Cancer treatment and survivorship statistics, 2022
2022 Standout
Exercise in adult and pediatric hematological cancer survivors: an intervention review
2010
Effect of physical exercise on muscle mass and strength in cancer patients during treatment—A systematic review
2013
Tumors that look for their springtime in APRIL
2009
Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukemia
2007
A view on drug resistance in cancer
2019 StandoutNature
Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials
2013
CNS pharmacokinetics of antifungal agents
2007
Subtype-specific β-adrenoceptor signaling pathways in the heart and their potential clinical implications
2004
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis
2007
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
2011
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis
2013
Attention to principles of exercise training: a review of exercise studies for survivors of cancers other than breast
2013
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
2012
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
Malignancy in Renal Transplantation
2004
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Cancer-associated cachexia
2018 Standout
Therapeutic effects of aerobic and resistance exercises for cancer survivors: a systematic review of meta-analyses of clinical trials
2018
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Cerebral aspergillosis: tissue penetration is the key
2009
Efficacy of Exercise Interventions in Patients with Acute Leukemia: A Meta-Analysis
2016
Regulation of cancer cell metabolism
2011 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Targeting apoptosis in cancer therapy
2020 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Myasthenia gravis
2019 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis
2008
Why is cancer drug discovery so difficult?
2006
Paradoxical roles of the immune system during cancer development
2006 Standout
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
2015
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Effect of Exercise on Cancer-Related Fatigue
2014
Dendritic cells: Understanding immunogenicity
2007 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Estimates of cancer incidence and mortality in Europe in 2008
2010 Standout
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
CNS pharmacokinetics of antifungal agents
2007
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
2018
General principles of tumor immunotherapy : basic and clinical applications of tumor immunology
2007
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Prevention and Treatment of Cancer-Related Infections
2012
Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States
2017
Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
2006
The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab
2007
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
2018
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Evolution of the immune system in humans from infancy to old age
2015 Standout
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
2008
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites
2010
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Exercise interventions on health-related quality of life for people with cancer during active treatment
2012
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Physical activity for women with breast cancer after adjuvant therapy
2018
The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials
2019
Adult nodular lymphocyte‐predominant Hodgkin lymphoma: treatment modality utilization and survival
2018
CAR T cell immunotherapy for human cancer
2018 StandoutScience
The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.
2006
Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes
2007 StandoutNobel
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Works of Thomas Elter being referenced
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman
2006
Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome
2005
Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial
2011
Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma?
2009
Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention
2011
Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure
2001
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
2003
Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab
2008
A phase Ib trial of atacicept (TACI-Ig) to neutralize APRIL and BLyS in patients with refractory or relapsed B-cell chronic lymphocytic leukemia (B-CLL)
2007
Aerobic physical exercise for adult patients with haematological malignancies
2014
Fludarabine in Combination With Alemtuzumab Is Effective and Feasible in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: Results of a Phase II Trial
2005
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
2007
Alemtuzumab for patients with chronic lymphocytic leukaemia
2012
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
2011
Fludarabine in chronic lymphocytic leukaemia
2006
Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic Review
2016